Compare Sibanye Stillwater Ltd (SBSW) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sibanye Stillwater Ltd vs Tempus AI — how do they compare? Sibanye Stillwater Ltd trades at $10.1 (market cap $6.89B), while Tempus AI trades at $70.04 (market cap $12.77B). The key difference: Tempus AI is the larger of the two by market cap, and Sibanye Stillwater Ltd pays a 8.36% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sibanye Stillwater Ltd for 51 Days and Tempus AI for 22 Days on average.
| SBSW | TEM | |
|---|---|---|
Market Cap | $6.89B | $12.77B |
Volume | 5,024,779 | 8,980,490 |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $21.12 | $99.28 |
52-Week Low | $8.00 | $41.55 |
Typical Hold Time | 51 Days | 22 Days |
Enterprise Value | $7.79B | $13.40B |
Dividend Yield | 8.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sibanye Stillwater (SBSW) trades at $9.91, down 1.0% on the day, with a bearish technical signal from moving averages and oscillators. Fundamentally, the company reported a net loss of $5.17 billion in 2025 despite revenue of $129.68 billion, though 2026 projections show a return to profitability. Recent news highlights strong first-half 2026 results, including 54% revenue growth and a 111% surge in EBITDA, signaling a potential operational turnaround.
The outlook is mixed: analyst consensus is a 'Buy' with a $14.25 price target, implying significant upside, but risks include volatile commodity prices, high debt levels, and inconsistent earnings history. The stock offers value with low P/E and P/S ratios, yet investors must weigh the bullish analyst sentiment against underlying financial volatility and macroeconomic pressures on mining sectors.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
